Le Lézard
Classified in: Health
Subjects: NPT, LEG

National Kidney Foundation Applauds Landmark Immunosuppressive Drug Coverage Legislation Passed in the U.S. Senate

NEW YORK, Dec. 22, 2020 /PRNewswire/ -- "Today the U.S. Senate passed landmark immunosuppressive drug legislation, which has the potential to save the lives of kidney transplant patients throughout our nation.

"The National Kidney Foundation applauds Senator Bill Cassidy (R-LA) and Senator Richard Durbin (D-IL) for their leadership in passing legislation to extend Medicare coverage of immunosuppressive drugs for kidney transplant patients. The legislation represents a significant change which will greatly help save patients' lives and taxpayers money.

"The National Kidney Foundation sincerely thanks our grassroots advocates who have been fighting alongside us in support of this critical legislation for years.

"Kidney transplant patients must take immunosuppressive drugs for the life of their transplant to help prevent organ rejection. Skipping even one dose will increase the chance of organ failure. But when the current 36-month Medicare coverage for this life-saving medication ends, patients are forced to make a choice between paying for their transplant medications or paying the rent, it's a choice nobody should have to make.

"We are grateful to Congressmen Ron Kind (D-WI) and Michael Burgess (R-TX) who introduced similar legislation in the House earlier this year, and for their leadership in ensuring bi-partisan support for this critically important legislation. 

"The National Kidney Foundation sincerely thanks the Administration for their strong backing of this legislation that will greatly help our nation's kidney transplant recipients."

For a patient's perspective on how a lack of Medicare coverage for immunosuppressive drugs affects a family see Bobbie's story.

About Kidney Disease
In the United States, 37 million adults are estimated to have chronic kidney disease (CKD)?and approximately 90 percent don't know they have it.  1 in 3 adults in the U.S. is at risk for chronic kidney disease.  Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history. People who are Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian American, or Native Hawaiian or Other Pacific Islander are at increased risk for developing the disease. Black or African American people are almost 4 times more likely than Whites to have kidney failure. Hispanic or Latino people are 1.3 times more likely than non-Hispanics or Latinos to have kidney failure.

Approximately 750,000 Americans have irreversible kidney failure and need dialysis or a kidney transplant to survive. More than 500,000 of these patients receive dialysis at least three times per week to replace kidney function. Nearly 100,000 Americans are on the waitlist for a kidney transplant right now.  Depending on where a patient lives, the average wait time for a kidney transplant can be upwards of three to seven years. Living organ donation not only saves lives, it saves money. Each year, Medicare spends approximately $89,000 per dialysis patient and less than half, $35,000, for a transplant patient.

About National Kidney Foundation Living Organ Donation Resources:
THE BIG ASK: THE BIG GIVE platform, which provides nationwide outreach, is designed to increase kidney transplantation through training and tools that help patients and families find a living donor. It includes direct patient and caregiver support through our toll-free help line 855-NKF-CARES, peer mentoring from a fellow kidney patient or a living donor, online communities, an advocacy campaign to remove barriers to donation, and a multi-media public awareness campaign. All resources are free and designed to teach kidney patients, or their advocates, how to make a "big ask" to their friends, loved ones, or community to consider making a "big give," a living organ donation. www.kidney.org/livingdonation.

The National Kidney Foundation (NKF) is the largest, most comprehensive and longstanding organization dedicated to the awareness, prevention and treatment of kidney disease. For more information about NKF visit www.kidney.org.

Twitter: @NKF 

SOURCE National Kidney Foundation

These press releases may also interest you

at 16:15
Veracyte, Inc. today announced financial results for the second quarter ended June 30, 2021, and provided an update on recent business progress. "Our business demonstrated significant momentum in the second quarter, with particularly strong growth...

at 16:12
eHealth, Inc. , a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2021. View the full press release in PDF. The news release and earnings presentation can be accessed on...

at 16:10
CytRx Corporation ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced that based on results from its 2021 Annual Meeting...

at 16:10
ICARE AD-US is an observational real-world phase 4 study designed to evaluate the safety and effectiveness of ADUHELM in clinical practiceICARE AD-US is one of three programs to generate post-approval data on ADUHELM, including the re-dosing Phase 3b...

at 16:09
Welltower® Inc.  has issued the following business update which can be found at: https://welltower.com/july-business-update About WelltowerWelltower® Inc. , an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health...

at 16:08
The National Association for Home Care & Hospice (NAHC) and Partnership for Quality Home Healthcare (PQHH) today commended the introduction of the Choose Home Care Act of 2021. The bipartisan legislation, introduced by Senators Debbie Stabenow (D-MI)...

News published on 22 december 2020 at 08:17 and distributed by: